Profile Image

Professor Shu Chuen Li

Professor

School of Biomedical Sciences and Pharmacy (Pharmacy and Experimental Pharmacology)

Career Summary

Biography

Professor Shu Chuen Li is Chair Professor and Discipline Convenor, Discipline of Pharmacy and Experimental Pharmacology.

Before taking up the present position, Professor Li has worked as an academic at the National University of Singapore and as Acting Director and Deputy Director, Pharmaceutical Evaluation Section (PES) of Pharmaceutical Benefits Branch, Commonwealth Department of Health & Ageing in Canberra.

During his period in Singapore, besides his academic appointment, Professor Li also served as the Visiting Specialist and Consultant to the Health Sciences Authority (which is the Singaporean equivalent of FDA in the USA and TGA in Australia). In this capacity, Professor Li has been instrumental in developing the Pharmacoeconomics and Drug Utilization Unit at the Centre for Drug Administration, Health Sciences Authority and in organizing several of the first ever pharmaceoconomics and outcomes conferences in the region. In his capacity as Acting Director and Deputy Director of PES in Australia, Professor Li was among the few pioneers that put the principles of pharmacoeconomic evaluation into practice for regulatory affairs, and has been involved in the implementation of the first version of the Australian Pharmacoeconomics Guidelines and the development of the second version of the same Guidelines.

Professor Li has been very active in his research area of pharmacoeconomics and outcomes research as well as pharmacy practice. He has published more than 250 peer review articles and conference abstracts on the subjects. In the past few years, Professor Li has been invited to present more than 100 lectures and panel speeches about pharmacy practice, drug policies and pharmacoeconomic applications in various countries and jurisdictions.

Professor Li was a Director on the ISPOPR Board of Directors from 2006 to 2008, and a founding member of the ISPOR Asia Consortium. Based in the United States, ISPOR is the peak academic society on pharmacoeconomics and outcomes research worldwide.

Besides the aforementioned commitments, Professor Li also holds many other consultative positions in Australia and in various Asian countries. The main ones include:

1. Visiting Professor, Department of Pharmacy, National University of Singapore

2. Visiting Professor, School of Pharmacy, Fudan University, China

3. Visiting Professor, Faculty of Pharmaceutical Science, Prince of Songkla University in Thailand.

4.Visiting Specialist/Consultant, Centre for Drug Administration, Health Sciences Authority, Singapore

5. Visiting Specialist/Consultant, Centre for Health Services Research, Yong Loo Lin School of Medicine, National University of Singapore.

Research Expertise

I have been involved with research in clinical pharmacy for more than 20 years. Recently, my research interest has been concentrated more on the areas of pharmacoeconomics and outcomes research, as well as drug policy. As a matter of fact, I would be considered as one of the pioneers in applying pharmacoeconomics in drug regulation, as I was involved with the first implementation of the first ever published pharmacoeconomics guidelines in drug reimbursement when I worked for the Commonwealth Government in Australia.



Teaching Expertise

I have been teaching pharmacoeconomics and outcomes research as well as pharmacotherapy for nearly 10 years. I have also been invited to provide lectures and workshops around the South-east Asian region during my period working at the National University of Singapore. I have also conducted courses for critical literature evaluation and biostatistics at the graduate level for nearly 10 years.



Administrative Expertise

I have been the acting director and deputy director at one of the Commonwealth Government department in Canberra for around 5 years. Before that I held senior pharmacist position as well as chief pharmacist and chief hospital administrator in Republic of Nauru for a period of 2 years.

During the course of my career, I have been involved in handling many adminsitrative decisions and I have completed a degree of Master of Business Administration to provide the theoretcial consolidation of my administrative experience.



Collaborations


Qualifications

  • PhD, Monash University
  • Bachelor of Pharmacy, South Australian Institute of Technology
  • Master of Applied Science, South Australian Institute of Technology
  • Post Graduate Diploma in Management, Deakin University
  • Health Economics (Distance Education), Monash University

Keywords

  • Biostatistics
  • Clinical Pharmacy
  • Clinical Pharmacy Practice
  • Cost-effectiveness studies
  • Critical Literature Evaluation
  • Drug Policy
  • Health economics
  • Health services research
  • Outcomes Research
  • Patient reported outcomes studies
  • Pharmacoeconomics
  • Pharmacoepidemiology
  • Pharmacotherapeutics

Languages

  • Cantonese (Fluent)
  • Hakka (Fluent)
  • Mandarin (Fluent)

Fields of Research

CodeDescriptionPercentage
111299Oncology and Carcinogenesis not elsewhere classified15
110399Clinical Sciences not elsewhere classified45
111799Public Health and Health Services not elsewhere classified40

Professional Experience

UON Appointment

DatesTitleOrganisation / Department
1/01/2014 - ProfessorUniversity of Newcastle
School of Biomedical Sciences and Pharmacy
Australia

Academic appointment

DatesTitleOrganisation / Department
1/05/2007 - Visiting ProfessorFudan University
China
1/04/2007 - 22/06/2015Visiting ProfessorNational University of Singapore
Singapore
1/05/2006 - Board of DirectorsInternational Society of Pharmacoeconomics & Outcomes Research (ISPOR)
United States
1/05/1998 - 1/12/2006Associate ProfessorNational University of Singapore
Department of Pharmacy
Singapore
1/09/1997 - 1/05/1998Acting DirectorCommonwealth Department of Health and Family Services
Australia
1/07/1995 - 1/08/1997Deputy Director
<table border="0" cellpadding="0" cellspacing="0" width="83"><colgroup><col width="83" /></colgroup><tbody><tr height="19"><td height="19" style="height:14.4pt;width:62pt;" width="83">Drug regulation</td></tr></tbody></table>
Commonwealth Department of Health and Family Services
Australia
1/01/1992 - 1/12/1993Special Subject LecturerMonash University
Australia
1/01/1978 - 1/01/1979Graduate Trainee PharmacistRoyal Adelaide Hospital
Department of Pharmacy
Australia

Professional appointment

DatesTitleOrganisation / Department
1/07/2001 - Consultant/Visitng SpecialistCentre for Drug Administration, Ministry of Health, Republic of Singapore
Singapore
1/03/1994 - 1/07/1994Senior Pharmacist & Clinical Trials CoordinatorAlfred Hospital
Department of Pharmacy
Australia
1/04/1985 - 1/03/1994Clinical Pharmacist (Research & Education)Alfred Hospital
Department of Clinical Pharmacology
Australia
1/01/1983 - 1/02/1985Chief Pharmacist & Chief Administrative OfficerNauru Phosphate Corporation Hospital, Republic of Nauru
Nauru Phospohate Corporation Hospital, Republic of Nauru
Papua New Guinea
1/02/1982 - 1/08/1982Pharmacy managerEvans Pharmacy
Kimba in South Australia
Australia

Invitations

Participant

YearTitle / Rationale
2007Health Policy Dinner Symposium
Organisation: Fudan University and Chinese University of Hong Kong
2007Conference on Quality of Life in Asia
Organisation: Hong Kong Society for Quality of Life, Academy of Medicine
2006Symposium on New Standard for Hepatitis B Management
Organisation: Chapter of Gastroenterologists, College of Physicians, Singapore
2006Third International Asian Conference on Cancer Screening
Organisation: Health Promotion Board
2006Pre-Conference Workshop at ISPOR 2nd Asia Pacific Conference
Organisation: ISPOR
2006IMS Special Symposium at ISPOR 2nd Asia Pacific Conference
Organisation: IMS & ISPOR
2006Co-sponsor Special Session at ISPOR 2nd Asia Pacific Conference
Organisation: ISPOR & Various regulatory authroities in Asia
2006Faculty of Science Lunchtime Seminar
Organisation: Faculty of Science, National University of Singapore
2006Continuous Education Lecture
Organisation: Pharmaceutical Society of Singapore Industry Chapter
200615th Annual Scientific Meeting
Organisation: Singapore General Hospital
2006Advanced GCP course on Pharmacovigilance
Organisation: Yong Loo Lin School of Medicine, National University of Singapore
2006Training Workshop for National Healthcare Group College
Organisation: National Healthcare Group
2006Second Regional Conference on Cost-effective Healthcare
Organisation: SingHealth Postgraduate Medical Institute
2005Third Asia Pacific Evidence-Based Medicine Conference and Workshop,
Organisation: National University of Singapore & McMaster University of Canada
2005Invited Talk
Organisation: Centre for Pharmaceutical Administration, Health Sciences Authority
2005Pfizer Global Pharmaceuticals Outcomes Research Training Programme Part 1
Organisation: Pfizer Asia
2005Presentation Talk at Science Focus for Teachers Program
Organisation: Ministry of Education & Faculty of Science, National University of Singapore
2005Intervarsity Symposium Singapore, 17th Singapore Pharmacy Congress
Organisation: Pharmaceutical Society of Singapore & National University of Singapore
2005Patient Reported Outcomes for Clinical Research Workshop.17th Singapore Pharmacy Congress
Organisation: Pharmaceutical Society of Singapore
2005Dinner Symposium of Osteoporosis Society of Singapore
Organisation: Osteoporosis Society of Singapore Special Interest Group Meeting,
2005Pfizer Outcomes Research Coordinators of Asia Training Program Part 2
Organisation: Pfizer Asia
2005COFM Public Health Update Forum
Organisation: Chapter of Public Health & Occupational Physicians, Academy of Medicine, Singapore and Department of Community, Occupational and Family Medicine, Faculty of Medicine, National University of Singapore.
2005Health Economic Symposium
Organisation: Vietnamese Ministry of Health & Sanofi-Aventis
2005TASPOR Annual Health Economics Meeting and Symposium
Organisation: TASPOR
200521st Federation of Asian Pharmaceutical Associations (FAPA) Congress
Organisation: FAPA
2004Invited Lecture
Organisation: at Faculty of Pharmaceutical Sciences, Prince of Songkla University
2004Regional Conference on Cost-effective Healthcare
Organisation: SGH Postgraduate Medical Institute Healthcare Management Development Programme
2004Medical Decision Workshop
Organisation: Tan Tock Seng Hospital, Singapore, Institute of Medical Education and Training (IMET), NHG College
20041st National Health Outcomes Conference
Organisation: Association Of Public Health Medical Specialist and Pfizer Malaysia Sdn. Bhd
2004Post Conference Workshop, 1st National Health Outcomes Conference
Organisation: Association Of Public Health Medical Specialist and Pfizer Malaysia Sdn. Bhd
2004Regional Conference on Cost-effective Healthcare,
Organisation: SGH Postgraduate Medical Institute Healthcare Management Development Programme
2004. Pre-Conference Workshop, Regional Conference on Cost-effective Healthcare,
Organisation: SGH Postgraduate Medical Institute Healthcare Management Development Programme
20042nd VALID Steering Committee Meeting
Organisation: Sanofi-Aventis
2003Proceedings of International Congress of Indian Pharmacy Graduate
Organisation: Pharmaceutical Society of India
2003Dinner Symposium: New advances on lipid lowering therapy.
Organisation: Pharmaceutical Society of Singapore
20031st VALID Study Steering Committee Meeting,
Organisation: Sanofi-Aventis
2003Panel Discussion at ISPOR First Asian Pacific Conference
Organisation: ISPOR
2003Pre-conference workshop of ISPOR First Asian Pacific Conference
Organisation: ISPOR
2003Roundtable Discussion for Chinese Delegation. ISPOR First Asian Pacific Conference,
Organisation: GSK
20031st National Health Outcomes and Pharmacoeconomics Symposium
Organisation: National University of Singapore, Pfizer Asia and Tan Tock Seng Hospital
2002Invited Lecture
Organisation: Institute of Health Economics and Policy
2002Invited Lecture
Organisation: Kyoto University
2002International Workshop on Pharmacoeconomics:
Organisation: Indonesian Ministry of Health
2002Invited Lecture
Organisation: University of Tokyo
2002Asian Pacific Forum on New Therapies in Rheumatic Diseases.
Organisation: National Arthritis Foundation
2002Invited Lecture
Organisation: National Healthcare Group P & T Co-ordinating Committee
2002Workshop on Healthcare Financing
Organisation: Pharmaceutical Association of Malaysia
200215th Singapore Pharmacy Congress
Organisation: Pharmaceutical Society of Singapore
2002Pharmacoeconomics for Pharmacists Workshop
Organisation: Pharmaceutical Society of Singapore
2001Invited Lecture
Organisation: Centre of Pharmaceutical Administration, Health Sciences Authority
2001First International Pharmaceutical Students Federation Asian Pacific Symposium
Organisation: IPSF of FIP
2001Third Annual Scientific Meeting
Organisation: Johor State Department of Health
2001An Evidence Based and Pharmacoeconomic Approach to Drug Prescribign Seminar
Organisation: National University Hospital Pharmacy and Therapeutics Committee
Edit

Publications

For publications that are currently unpublished or in-press, details are shown in italics.


Journal article (146 outputs)

YearCitationAltmetricsLink
2014Gao L, Xia L, Pan S-Q, Xiong T, Li S-C, 'Reliability and validity of QOLIE-10 in measuring health-related quality of life (HRQoL) in Chinese epilepsy patients', Epilepsy Research, (2014) [C1]

Objectives: We aimed to translate and validate a short-form of Quality of Life Inventory in Epilepsy-89 (QOLIE-89)-QOLIE-10 for use in the busy clinical setting. Methods: Accepted procedures were adopted to translate the QOLIE-10. Patients with epilepsy from two tertiary hospitals in China were asked to complete a standardized questionnaire including QOLIE-10, EQ-5D, QWB-SA and Mini Mental State Examination (MMSE). Construct validity was assessed via factor analysis. Convergent validity was explored via the correlations between QOLIE-10 and other external measures. The ability of QOLIE-10 to differentiate between epilepsy-specific variables was tested to examine the discriminant validity. Cronbach's alpha was calculated to test the reliability. Additionally, HRQoL according to different epilepsy-specific variables was compared. Results: 220 Respondents completed QOLIE-10 and EQ-5D, among which 141 subjects completed QWB-SA and MMSE. Two subscales were yielded in the factor analysis. The correlations between QOLIE-10 scores and EQ-5D, QWB-SA, MMSE were significant thus demonstrated the convergent validity. Furthermore, QOLIE-10 was able to differentiate patients with various seizure frequency, refractory epilepsy and antiepileptic treatment. The Cronbach's alpha was 0.853. In general, more predictive variables were identified to associate with QOLIE-10 scores than the other two instruments. Comorbidity (0.015), numbers of AEDs (0.037), seizure types (0.041) and refractory epilepsy (0.016) were potential predictors of HRQoL, whereas there were fewer predictors for HRQoL or HRQoL. Conclusions: QOLIE-10 appeared to be a reliable and sensitive instrument to assess the HRQoL for epilepsy patients. According to the MLR analyses, numbers of AEDs, refractory epilepsy, comorbidity depression, and cognitive function were demonstrated to be predictors of HRQoL dependent on different tools. Comparisons between the tools suggested epilepsy-specific instrument was more competent to discriminate HRQoL based on condition variables. However, a longitudinal study is still needed to examine the responsiveness of Chinese QOLIE-10. © 2014 Elsevier B.V. All rights reserved.

DOI10.1016/j.eplepsyres.2014.01.007
2014Gao L, Li S-C, Xia L, Pan S, Velakoulis D, Walterfang M, 'Validation of the Chinese version of the NUCOG cognitive screening tool in patients with epilepsy, dementia and other neurological disorders', Journal of Clinical Neuroscience, 21 980-987 (2014)
DOI10.1016/j.jocn.2013.09.020
2014Gao L, Li S-C, Xia L, Pan S, Velakoulis D, Walterfang M, 'Validation of the Chinese version of the NUCOG cognitive screening tool in patients with epilepsy, dementia and other neurological disorders', Journal of Clinical Neuroscience, 21 980-987 (2014) [C1]

We aimed to develop and validate a Chinese version of the Neuropsychiatry Unit Cognitive Assessment Tool (NUCOG) for use in Chinese-speaking subjects internationally. Patients and healthy controls were recruited from two hospitals between July and October 2012. Receiver operating characteristic (ROC) curves were utilized to test criterion validity. Convergent validity was assessed via correlations between NUCOG and the Mini-Mental State Examination (MMSE). Reliability was measured by internal consistency (Cronbach's a). Patients with epilepsy (n = 144), neurological diseases (n = 81), dementia (n = 44), and controls (n = 260) completed the NUCOG and the MMSE. Overall, both NUCOG and MMSE scores differed significantly across the four groups with the highest scores in the control group and the lowest in the dementia group (p < 0.0001). The NUCOG scores could differentiate between patients with certain seizure types, stroke and transient ischemic attack. Compared to the MMSE, the NUCOG exhibited a higher area under the ROC curve. The convergent validity was substantially correlated, and internal consistency was very high (0.922). The Chinese version of NUCOG was demonstrated to be a sensitive and reliable screening tool for cognitive impairment in a Chinese-speaking population not only in China, but also in countries where there is a sizeable population of ethnic Chinese. Additionally, our study also showed the NUCOG could better differentiate cognitive function in patients with certain seizure types, stroke and transient ischemic attack than the MMSE. This potentially expands the clinical usefulness of NUCOG, enabling clinicians to measure the cognitive profile of patients with epilepsy and ischemic cerebrovascular diseases. © 2013 Elsevier Ltd. All rights reserved.

DOI10.1016/j.jocn.2013.09.020
2014Gao L, Xia L, Pan S-Q, Xiong T, Li S-C, 'Psychometric properties of Chinese language Liverpool Seizure Severity Scale 2.0 (LSSS 2.0) and status and determinants of seizure severity for patients with epilepsy in China', EPILEPSY & BEHAVIOR, 31 187-193 (2014) [C1]
DOI10.1016/j.yebeh.2013.12.011Author URL
CitationsScopus - 1Web of Science - 1
2013Gao L, Xia L, Pan S-Q, Xiong T, Li S-C, 'Validation of a Chinese version of the Quality of Well-Being Scale-Self-Administered (QWB-SA) in patients with epilepsy', EPILEPSIA, 54 1647-1657 (2013) [C1]
DOI10.1111/epi.12324Author URL
CitationsScopus - 4Web of Science - 3
2013Gao L, Xia L, Zhao F-L, Li S-C, 'Clinical efficacy and safety of the newer antiepileptic drugs as adjunctive treatment in adults with refractory partial-onset epilepsy: A meta-analysis of randomized placebo-controlled trials', EPILEPSY RESEARCH, 103 31-44 (2013) [C1]
DOI10.1016/j.eplepsyres.2012.06.005Author URL
CitationsScopus - 12Web of Science - 11
2013Zhao YJ, Tan LCS, Au WL, Heng DMK, Soh IAL, Li SC, et al., 'Estimating the lifetime economic burden of Parkinson's disease in Singapore', EUROPEAN JOURNAL OF NEUROLOGY, 20 368-374 (2013) [C1]
DOI10.1111/j.1468-1331.2012.03868.xAuthor URL
CitationsScopus - 2Web of Science - 1
2013Zhou HJ, Li SC, Naidoo N, Zhu F, Yeoh KG, 'Empirical evidence of the continuing improvement in cost efficiency of an endoscopic surveillance programme for gastric cancer in Singapore from 2004 to 2010', BMC HEALTH SERVICES RESEARCH, 13 (2013) [C1]
DOI10.1186/1472-6963-13-139Author URL
CitationsScopus - 1Web of Science - 1
2013Zhang F, Xie J, Zhang Y, Kong L, Li S, '"What Is Important During the Selection of Traditional Chinese Medicine (TCM) in a Health Care Reimbursement or Insurance System?" Critical Issues of Assessment from the Perspective of TCM Practitioners', Value in Health Regional Issues, 2 141-146 (2013) [C1]
DOI10.1016/j.vhri.2013.01.004Author URL
2013Zhao F, Gao L, Li S, 'Burden of Disease Studies in the Asia-Pacific Region: Are There Enough being Performed to Provide Information for Evidence-Based Health Policy?', Value in Health Regional Issues, 2 152-159 (2013) [C1]
DOI10.1016/j.vhri.2013.02.007Author URL
CitationsScopus - 3
2012Tu H-AT, Rozenbaum MH, Coyte PC, Li SC, Woerdenbag HJ, Postma MJ, 'Health economics of rotavirus immunization in Vietnam: Potentials for favorable cost-effectiveness in developing countries', Vaccine, 30 1521-1528 (2012) [C1]
CitationsScopus - 7Web of Science - 6
2012Gao L, Zhao F, Li SC, 'Cost-utility analysis of liraglutide versus glimepiride as add-on to metformin in type 2 diabetes patients in China', International Journal of Technology Assessment in Health Care, 28 436-444 (2012) [C1]
CitationsScopus - 2Web of Science - 3
2012Gao L, Zhao F, Li SC, 'Statin is a reasonable treatment option for patients with polycystic ovary syndrome: A meta-analysis of randomized controlled trials', Experimental and Clinical Endocrinology and Diabetes, 120 367-375 (2012) [C1]
CitationsScopus - 17Web of Science - 11
2012Zhang F, Kong L-L, Zhang Y-Y, Li SC, 'Evaluation of impact on health-related quality of life and cost effectiveness of traditional chinese medicine: A systematic review of randomized clinical trials', Journal of Alternative and Complementary Medicine, 18 1108-1120 (2012) [C1]
CitationsScopus - 4Web of Science - 2
2012Zhang X-H, Li SC, Xie F, Lo N-N, Yang K-Y, Yeo S-J, et al., 'An exploratory study of response shift in health-related quality of life and utility assessment among patients with osteoarthritis undergoing total knee replacement surgery in a tertiary hospital in Singapore', Value in Health, 15 S72-S78 (2012) [C1]
CitationsScopus - 5Web of Science - 5
2012Zhou HJ, So JBY, Yong WP, Luo N, Zhu F, Naidoo N, et al., 'Validation of the functional assessment of cancer therapy-gastric module for the Chinese population', Health and Quality of Life Outcomes, 10 1-8 (2012) [C1]
CitationsScopus - 4Web of Science - 4
2012Thoopputra T, Newby DA, Schneider JJ, Li SC, 'Survey of diabetes risk assessment tools: Concepts, structure and performance', Diabetes/Metabolism Research and Reviews, 28 485-498 (2012) [C1]
CitationsScopus - 7Web of Science - 4
Co-authorsDavid Newby, Jennifer Schneider
2012Zhang X-H, Tan K, Tan H-H, Thumboo J, Li SC, 'Are English and Chinese versions of the audit of diabetes-dependent quality of life equivalent? An exploratory study based on the universalist approach', Value in Health Regional Issues, 1 75-81 (2012) [C1]
2012Tu HAT, Woerdenbag HJ, Riewpaiboon A, Kane S, Le DM, Postma MJ, Li SC, 'Cost of illness of chronic hepatitis B infection in Vietnam', Value in Health Regional Issues, 1 23-28 (2012) [C1]
2012Tu HAT, De Vries R, Woerdenbag HJ, Li SC, Le HH, Van Hulst M, Postma MJ, 'Cost-effectiveness analysis of hepatitis B immunization in Vietnam: Application of cost-effectiveness affordability curves in health care decision making', Value in Health Regional Issues, 1 7-14 (2012) [C1]
2011Tu H-AT, Woerdenbag HJ, Kane S, Rozenbaum MH, Li SC, Postma MJ, 'Economic evaluations of rotavirus immunization for developing countries: A review of the literature', Expert Review of Vaccines, 10 1037-1051 (2011) [C1]
DOI10.1586/erv.11.65
CitationsScopus - 14Web of Science - 10
2011Xie F, Ye H, Zhang Y, Liu X, Lei T, Li SC, 'Extension from inpatients to outpatients: Validity and reliability of the Oxford Knee Score in measuring health outcomes in patients with knee osteoarthritis', International Journal of Rheumatic Diseases, 14 206-210 (2011) [C1]
DOI10.1111/j.1756-185X.2010.01580.x
CitationsScopus - 4Web of Science - 4
2011Zhao F, Yue M, Yang H, Wang TA, Wu J-H, Li SC, 'Willingness to pay per quality-adjusted life year: Is one threshold enough for decision-making? Results from a study in patients with chronic prostatitis', Medical Care, 49 267-272 (2011) [C1]
CitationsScopus - 15Web of Science - 10
2011Zhao YJ, Tan LCS, Li SC, Au WL, Seah SH, Lau PN, et al., 'Economic burden of Parkinson's disease in Singapore', European Journal of Neurology, 18 519-526 (2011) [C1]
DOI10.1111/j.1468-1331.2010.03210.x
CitationsScopus - 8Web of Science - 8
2011Zhao YJ, Wee HL, Au WL, Seah SH, Luo N, Li SC, Tan LCS, 'Selegiline use is associated with a slower progression in early Parkinson's disease as evaluated by Hoehn and Yahr stage transition times (vol 17, pg 194, 2011)', PARKINSONISM & RELATED DISORDERS, 17 299-300 (2011) [C3]
DOI10.1016/j.parkreldis.2011.02.015Author URL
CitationsScopus - 1Web of Science - 1
2011Zhao YJ, Wee HL, Au WL, Seah SH, Luo N, Li SC, Tan LCS, 'Selegiline use is associated with a slower progression in early Parkinson's disease as evaluated by Hoehn and Yahr Stage transition times', Parkinsonism and Related Disorders, 17 194-197 (2011) [C1]
DOI10.1016/j.parkreldis.2010.11.010
CitationsScopus - 6Web of Science - 5
2011Li SC, Aggarwal SK, 'Estimation of resource utilisation difference between lithium and valproate treatment groups from the VALID study', Journal of Medical Economics, 14 350-356 (2011) [C1]
CitationsScopus - 3
2010Zhao YJ, Wee HL, Chan Y-H, Seah SH, Au WL, Lau PN, et al., 'Progression of Parkinson's Disease as evaluated by Hoehn and Yahr stage Transition times', Movement Disorders, 25 710-716 (2010) [C1]
DOI10.1002/mds.22875
CitationsScopus - 20Web of Science - 13
2010Zhao F, Yue M, Yang H, Wang T, Wu J-H, Li SC, 'Health-related quality of life in Chinese patients with chronic prostatitis/chronic pelvic pain syndrome', Quality of Life Research, 19 1273-1283 (2010) [C1]
DOI10.1007/s11136-010-9697-2
CitationsWeb of Science - 8
2010Koh Y, Yap CW, Li SC, 'Development of a combined system for identification and classification of adverse drug reactions: Alerts Based on ADR Causality and Severity (ABACUS)', Journal of the American Medical Informatics Association, 17 720-722 (2010) [C2]
CitationsScopus - 3Web of Science - 2
2010Shi LZ, Hodges M, Drummond M, Ahn J, Li SC, Hu S, et al., 'Good research practices for measuring drug costs in cost-effectiveness analyses: An international perspective: The ISPOR Drug Cost Task Force Report-Part VI', Value in Health, 13 28-33 (2010) [C1]
DOI10.1111/j.1524-4733.2009.00662.x
CitationsScopus - 9Web of Science - 8
2010Soon SS, Goh SY, Bee YM, Poon JL, Li SC, Thumboo J, Wee HL, 'Audit of diabetes-dependent quality of life (ADDQoL) Chinese version for Singapore questionnaire: Reliability and validity among Singaporeans with type 2 diabetes mellitus', Applied Health Economics and Health Policy, 8 239-249 (2010) [C1]
DOI10.2165/11313920-000000000-00000
CitationsScopus - 9
2009Zhang X-H, Wee H-L, Tan K, Thumboo J, Li SC, 'Is diabetes knowledge associated with health-related quality of life among English-speaking subjects with diabetes in Singapore', Journal of Chinese Clinical Medicine, 4 144-150 (2009) [C2]
CitationsScopus - 1
2009Luo N, Tan LCS, Zhao Y, Lau P-N, Au W-L, Li SC, 'Determination of the longitudinal validity and minimally important difference of the 8-item Parkinson's Disease Questionnaire (PDQ-8)', Movement Disorders, 24 183-187 (2009) [C1]
DOI10.1002/mds.22240
CitationsScopus - 7Web of Science - 8
2009Yong C, Fisher DA, Sklar GE, Li SC, 'A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): An Asian perspective', International Journal of Antimicrobial Agents, 33 46-51 (2009) [C1]
DOI10.1016/j.ijantimicag.2008.07.016
CitationsScopus - 17Web of Science - 15
2009Zhang X-H, Li SC, Fong K-Y, Thumboo J, 'The Impact of Health Literacy on Health-Related Quality of Life (HRQoL) and utility assessment among patients with rheumatic diseases', Value in Health, 12 S106-S109 (2009) [C1]
DOI10.1111/j.1524-4733.2009.00640.x
CitationsScopus - 12Web of Science - 9
Co-authorsXu Zhang
2009Pongmesa T, Li SC, Wee H-L, 'A survey of knowledge on diabetes in the Central Region of Thailand', Value in Health, 12 S110-S113 (2009) [C1]
DOI10.1111/j.1524-4733.2009.00641.x
CitationsScopus - 2
2009Zhang X-H, Jin J, Ngorsuraches S, Li SC, 'Development and validation of a scale to measure patients' trust in pharmacists in Singapore', Patient Preference and Adherence, 3 1-7 (2009) [C1]
DOI10.1016/S1098-3015(10)64496-8
2009Zhang X-H, Thumboo J, Fong K-Y, Li SC, 'Development and validation of a Functional Health Literacy Test', The Patient: Patient-Centred Outcomes Research, 2 169-178 (2009) [C1]
DOI10.2165/11314850-000000000-00000
CitationsScopus - 1Web of Science - 1
2009Ong SC, Lim SG, Li SC, 'How big is the financial burden of hepatitis B to society? A cost-of-illness study of hepatitis B infection in Singapore', Journal of Viral Hepatitis, 16 53-63 (2009) [C1]
DOI10.1111/j.1365-2893.2008.01042.x
CitationsScopus - 7Web of Science - 10
2009Ong SC, Lim SG, Li SC, 'Cultural adaptation and validation of a questionnaire for use in hepatitis B patients', Journal of Viral Hepatitis, 16 272-278 (2009) [C1]
DOI10.1111/j.1365-2893.2009.01073.x
CitationsScopus - 1Web of Science - 1
2008Zhang X-H, Xie F, Wee H-L, Thumboo J, Li SC, 'Applying the expectancy-value model to understand health values', Value in Health, 11 S61-S68 (2008) [C1]
DOI10.1111/j.1524-4733.2008.00368.x
CitationsScopus - 4Web of Science - 4
2008Xie F, Thumboo J, Fong K-Y, Lo N-N, Yeo S-J, Yang K-Y, Li SC, 'A study on indirect and intangible costs for patients with knee osteoarthritis in Singapore', Value in Health, 11 S84-S90 (2008) [C1]
DOI10.1111/j.1524-4733.2008.00371.x
CitationsScopus - 11Web of Science - 8
2008Wee H-L, Li SC, Xie F, Zhang X-H, Luo N, Feeny D, et al., 'Validity, feasibility and acceptability of time trade-off and standard gamble assessments in health valuation studies: A study in a multiethnic Asian population in Singapore', Value in Health, 11 S3-S10 (2008) [C1]
DOI10.1111/j.1524-4733.2008.00361.x
CitationsScopus - 7Web of Science - 5
2008Wee H-L, Cheung Y-B, Loke W-C, Tan C-B, Chow M-H, Li SC, et al., 'The association of body mass index with health-related quality of life: An exploratory study in a multiethnic Asian population', Value in Health, 11 S105-S114 (2008) [C1]
DOI10.1111/j.1524-4733.2008.00374.x
CitationsScopus - 22Web of Science - 13
2008Tarn TYH, Hu SL, Kamae I, Yang BM, Li SC, Tangcharoensathien V, et al., 'Health-care systems and pharmacoeconomic research in Asia-Pacific region', Value in Health, 11 S137-S155 (2008) [C1]
DOI10.1111/j.1524-4733.2008.00378.x
CitationsScopus - 25Web of Science - 16
2008Jin J, Sklar GE, Oh VMS, Li SC, 'Factors affecting therapeutic compliance: A review of from the patient's perspective', Therapeutics and Clinical Risk Management, 4 269-286 (2008) [C1]
CitationsScopus - 117
2008Wee H-L, Li SC, Zhang X-H, Xie F, Feeny D, Luo N, et al., 'Are symbols useful and culturally acceptable in health-state valuation studies? An exploratory study in a multi-ethnic Asian population', Patient Preference and Adherence, 2 271-276 (2008) [C1]
DOI10.2147/PPA.S4142
2008Zhao YJ, Tan LCS, Lau PN, Au WL, Li SC, Luo N, 'Factors affecting health-related quality of life amongst Asian patients with Parkinson's disease', European Journal of Neurology, 15 737-742 (2008) [C1]
DOI10.1111/j.1468-1331.2008.02178.x
CitationsScopus - 23Web of Science - 24
2008Li SC, 'Can pharmacoeconomic guidelines be implemented successfully in Asia?', Journal of Medical Economics, 11 341-343 (2008) [C3]
DOI10.3111/13696990802221171
2008Lee KKC, Li SC, Kwong KS, Chan TYK, Lee VWY, Lau JTF, 'A study of the health and economic effects of influenza-like illness on the working population under different working environments of a large corporation in Hong Kong', Journal of Medical Economics, 11 639-650 (2008) [C1]
DOI10.3111/13696990802533179
CitationsScopus - 1
2008Koh Y, Yap CW, Li SC, 'A quantitative approach of using genetic algorithm in designing a probability scoring system of an adverse drug reaction assessment system', International Journal of Medical Informatics, 77 421-430 (2008) [C1]
DOI10.1016/j.ijmedinf.2007.08.010
CitationsScopus - 16Web of Science - 13
2008Ngorsuraches S, Lerkiatbundit S, Li SC, Sirithorn R, Korwiwattanakarn M, 'Development and Validation of Patient's Trust Scale in Community Pharmacist (Trust-Ph)', Research in Social and Administrative Pharmacy, 4 272-283 (2008) [C1]
DOI10.1016/j.sapharm.2007.10.002
CitationsScopus - 6Web of Science - 4
2008Li SC, Piggott C, 'A focus group study of barriers for female community pharmacists providing counselling for male sexual dysfunction', NSW Pharmacist, 15-16 (2008) [C3]
2008Ong SC, Mak B, Aung MO, Li SC, Lim S-G, 'Health-related quality of life in chronic hepatitis B patients', Hepatology, 47 1108-1117 (2008) [C1]
DOI10.1002/hep.22138
CitationsScopus - 45Web of Science - 39
2008Xie F, Lo NN, Lee HP, Cieza A, Li SC, 'Validation of the international classification of functioning, disability, and health (ICF) brief core set for osteoarthritis', Scandinavian Journal of Rheumatology, 37 450-461 (2008) [C1]
DOI10.1080/03009740802116216
CitationsScopus - 9Web of Science - 8
2008Xie F, Li SC, Goeree R, Tarride J-E, O'Reilly D, Lo N-N, et al., 'Validation of Chinese Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) in patients scheduled for total knee replacement', Quality of Life Research, 17 595-601 (2008) [C1]
DOI10.1007/s11136-008-9340-7
CitationsScopus - 21Web of Science - 18
2008Luo N, Seng B-K, Xie F, Li SC, Thumboo J, 'Psychometric evaluation of the Schizophrenia Quality of Life Scale (SQLS) in English- and Chinese-speaking Asians in Singapore', Quality of Life Research, 17 115-122 (2008) [C1]
DOI10.1007/s11136-007-9278-1
CitationsScopus - 4Web of Science - 3
2007Wee H-L, Li SC, 'Sociodemographic factors influencing the effectiveness of public health education: A comparison of two studies in Singapore', Annals Academy of Medicine Singapore, 36 958-961 (2007) [C1]
2007Wee HL, Loke WC, Li SC, Fong KY, Cheung YB, Machin D, et al., 'Cross-cultural adaptation and validation of Singaporean Malay and Tamil versions of the EQ-5D', Annals of the Academy of Medicine Singapore, 36 403-408 (2007) [C1]
CitationsWeb of Science - 9
2007Xie F, Thumboo J, Fong K-Y, Lo N-N, Yeo S-J, Yang K-Y, Li S-C, 'Direct and indirect costs of OA in Singapore: A comparative study among multiethnic Asian patients', JOURNAL OF RHEUMATOLOGY, 34 165-171 (2007)
Author URL
CitationsWeb of Science - 13
2007Xie F, Lo NN, Lee HP, Cieza A, Li SC, 'Validation of the comprehensive ICF core set for Osteoarthritis (OA) in patients with knee OA: A Singaporean perspective', Journal of Rheumatology, 34 2301-2307 (2007) [C1]
CitationsWeb of Science - 8
2007Xie F, Thumboo J, Li SC, 'Direct and Indirect Costs of Osteoarthritis: A Perspective from Multiethnic Asian Patients with Osteoarthritis in Singapore', Journal of Rheumatology, 34 165-171 (2007) [C1]
2007Xie F, Li S-C, Lo N-N, Yeo S-J, Yang K-Y, Yeo W, et al., 'Cross-cultural adaptation and validation of Singapore English and Chinese Versions of the Oxford Knee Score (OKS) in knee osteoarthritis patients undergoing total knee replacement', OSTEOARTHRITIS AND CARTILAGE, 15 1019-1024 (2007)
DOI10.1016/j.joca.2007.02.013Author URL
CitationsWeb of Science - 21
2007Xie F, Thumboo J, Lo NN, Yeo SJ, Yang KY, Yeo W, et al., 'Cross-Cultural Adaptation and Validation of Singapore English and Chinese Versions of the Lequesne Algofunctional Index of Knee in Asians with Knee Osteoarthritis in Singapore.', Osteoarthritis and Cartilage, 15 19-26 (2007) [C1]
DOI10.1016/j.joca.2006.06.013
CitationsWeb of Science - 6
2007Zhang XH, Li SC, Xie F, Lo NN, Yang KY, Yeo SJ, Thomboo J, 'Investigation of response shift in health-related quality of life among patients undergoing total knee replacement', VALUE IN HEALTH, 10 A253-A253 (2007)
DOI10.1016/S1098-3015(10)64947-9Author URL
2007Wee HL, Machin D, Loke WC, Cheung YB, Li SC, Luo N, et al., 'Assessing Systematic Differences in Utility Scores: A comparison of four widely used preference-based instruments', Value in Health, 10 256-265 (2007) [C1]
DOI10.1111/j.1524-4733.2007.00174.x
CitationsWeb of Science - 19
2007Li SC, 'How to improve pharmacoeconomic data generalisability between different countries', Expert Opinion on Pharmacotherapy, 8 1409-1413 (2007) [C3]
CitationsWeb of Science - 2
2007Wee HL, Ravens-Sieberer U, Erhart M, Li SC, 'Factor structure of the Singapore English version of the KINDL (R) children quality of life questionnaire', Health and Quality of Life Outcomes, 5 (2007) [C1]
DOI10.1186/1477-7525-5-4
CitationsWeb of Science - 10
2007Li SC, 'Health care system and public sector drug formulary in Singapore', ISPOR Connections, 13 4-7 (2007) [C2]
2007Xie F, Li SC, Luo N, Lo NN, Yeo SJ, Yang KY, et al., 'Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement', Arthritis and Rheumatism, 57 1043-1049 (2007) [C1]
DOI10.1002/art.22883
CitationsWeb of Science - 23
2007Xie F, Thumboo J, Li SC, 'True Difference or Something Else? Problems in Cost of Osteoarthritis Studies', Seminars in Arthritis and Rheumatism, 37 127-132 (2007) [C1]
DOI10.1016/j.semarthrit.2007.01.001
CitationsWeb of Science - 15
2007Luo N, Wang Q, Feeny D, Chen G, Li SC, Thumboo J, 'Measuring health preferences for health utilities index mark 3 health states: A study of feasibility and preference differences among ethnic groups in Singapore', Medical Decision Making, 27 61-70 (2007) [C1]
DOI10.1177/0272989x06297103
CitationsScopus - 4Web of Science - 5
2006Li SC, Ong SC, Lim SG, 'Health related quality of life in chronic hepatitis B patients', VALUE IN HEALTH, 9 A308-A308 (2006)
DOI10.1016/S1098-3015(10)63531-0Author URL
2006Zhang XH, Ngorsuraches S, Li SC, 'Development and Validation of a scale to measure patients trust in pharmacists', Value in Health, 9 (2006) [C1]
2006Chong LY, Chay OM, Li SC, 'Is the Childhood Asthma Questionnaire (CAQ) a good measure of Health-related Quality of Life (HRQoL) of Asthmatic Children in Asia? Validation of Childhood Asthma Questionnaire (CAQ B) Among Asthma Pediatric Patients in Singapore', PharmacoEconomics, 24 609-621 (2006) [C1]
DOI10.2165/00019053-200624060-00007
CitationsWeb of Science - 2
2006Wee HL, Tan CE, Goh SY, Li SC, 'Usefulness of the Audit of Diabetes-Dependent Quality-of-Life (ADDQOL) Questionnaire Patients with Diabetes in a multi-ethnic Asian country', PharmacoEconomics, 24 673-682 (2006) [C1]
DOI10.2165/00019053-200624070-00006
CitationsWeb of Science - 24
2006Wee HL, Chua HX, Li SC, 'Meaning of Health-related Quality-of-Life among children and adolescents in an Asian country: A focus group approach', Quality of Life Research, 15 821-831 (2006) [C1]
DOI10.1007/s11136-005-5092-9
CitationsWeb of Science - 9
2006Luo N, Seng BK, Thumboo J, Feeney D, Li SC, 'A Study of the Construct Validity of the Health Utilities Index Mark 3 (HUI3) in Patients with Schizophrenia', Quality of Life Research, 15 889-898 (2006) [C1]
DOI10.1007/s11136-005-5745-8
CitationsWeb of Science - 5
2006Wee HL, Li SC, Xie F, Zhang XH, Luo N, Cheung YB, et al., 'Are Asians comfortable with discussing death in health valuation studies? A qualitative study in multi-ethnic Singapore.', Health and Quality of Life Outcomes, 4 93-93 (2006) [C1]
DOI10.1186/1477-7525-4-93
CitationsWeb of Science - 1
2006Zhang XH, Xie F, Wee HL, Thumboo J, Li SC, 'Applying the Expectancy-Value Model to understand Health Preference An Exploratory Study.', Value in Health, 9 (3) (2006) [C3]
2006Wee HL, Li SC, Cheung YB, Fong YH, Thumboo J, 'The Influence of ethnicity on Health-related Quality of Life in Diabetes Mellitus: A Population-based Multi-Ethnic Study.', Journal of Diabetes and Its Complications, 20 170-178 (2006) [C1]
DOI10.1016/j.jdiacomp.2005.06.010
CitationsWeb of Science - 19
2006Xie F, Li SC, Roos E, Lo NN, Yeo SJ, Yang KY, et al., 'Cross-Cultural Adaptation and Validation of Singapore English and Chinese Versions of the Knee Injury and Osteoarthritis Outcome Score (KOOS) in Asians with Knee Osteoarthritis in Singapore', Osteoarthritis and Cartilage, 14 1098-1103 (2006) [C1]
DOI10.1016/j.joca.2006.05.005
CitationsWeb of Science - 25
2006Xie F, Li SC, Fong KY, Yeo SJ, Yang KY, Thumboo J, 'What Health Domains & Items Are Important to Patients with Knee Osteoarthritis? A Focus Group Study in a Multi-Ethnic Asian Population in Singapore', Osteoarthritis and Cartilage, 14 224-230 (2006) [C1]
DOI10.1016/j.joca.2005.09.009
CitationsWeb of Science - 19
2006Ngorsuraches S, Li SC, 'Thai Pharmacists'' Understanding, Attitudes, and Perceived Barriers Related to the Provision of Pharmaceutical Care', American Journal of Health-System Pharmacy, 63 2144-2150 (2006) [C1]
DOI10.2146/ajhp060054
CitationsWeb of Science - 6
2006Xie F, Thumboo J, Fong KY, Lo NN, Yeo SJ, Yang KY, Li SC, 'Are They Relevant? A Critical Evaluation of the International Classification of Functioning, Disability and Health Core Sets for Osteoarthritis from the Perspective of Patients with Knee Osteoarthritis in Singapore', Annals of the Rheumatic Diseases, 65 1067-1076 (2006) [C1]
DOI10.1136/ard.2005.043067
2005Koh Y, Li SC, 'A New Algorithm to Identify the Causality of Adverse Drug Reactions: Development of Algorithm', Drug Safety 2005, 28 1159-1161 (2005) [C3]
CitationsWeb of Science - 12
2005Xie F, Thumboo J, Li SC, 'Are they Relevant? A Critical Evaluation of the International Classification of Functioning, Disability and Health Core Sets for Osteoarthritis from the Perspective of Patients with Knee Osteoarthritis in Singapore', Annals of the Rheumatic Diseases, 8 1067-1073 (2005) [C1]
CitationsWeb of Science - 12
2005Chui WK, Li SC, 'Advice giving on self-medication by community pharmacists in Singapore', Journal of Clinical Pharmacy and Therapeutics, 30 225-231 (2005) [C1]
DOI10.1111/j.1365-2710.2005.00637.x
CitationsWeb of Science - 6
2005Hing WC, Yeoh TT, Yeoh SF, Lin R, Li SC, 'An evaluation of antimicrobial prophylaxis in paediatric surgery and its financial implication', Journal of Clinical Pharmacy and Therapeutics, 30 371-381 (2005) [C1]
DOI10.1111/j.1365-2710.2005.00659.x
CitationsWeb of Science - 7
2005Xie F, Tan CH, Li SC, 'Are They Used Safely? A Study on Prescribing Pattern of Selective Serotonin Reuptake Inhibitors in Singapore', Human Psychopharmacology, 20 459-465 (2005) [C1]
DOI10.1002/hup.711
CitationsWeb of Science - 3
2005Luo N, Tan LC, Li SC, Soh LK, Thumboo J, 'Validity and Reliability of the Chinese (Singapore) Version of the Parkinson''s Disease Questionnaire (PDQ-39).', Quality of Life Research, 14 273-279 (2005) [C3]
CitationsWeb of Science - 10
2005Wee HL, Lee WW, Ravens-Sieberer U, Erhart M, Li SC, 'Validation of the English Version of the KINDL Generic Children''s Health-related Quality of Life Instrument for an Asian Population - Results from a Pilot Test', Quality of Life Research, 14 1193-1200 (2005) [C3]
CitationsWeb of Science - 23
2005Xie F, Luo N, Li SC, 'The European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ-C30): Validation of English version in Singapore', Quality of Life Research, 14 1181-1186 (2005) [C3]
CitationsWeb of Science - 22
2005Zhang XH, Wee HL, Tan K, Tan K, Tan HH, Tan HH, et al., 'An Exploratory Study of the Equivalence between the English and Chinese Versions of the Audit of Diabetes-Dependent Quality of Life (ADDQOL) based on the Universalist Approach.', Quality of Life Research, 14 (2005) [C3]
2005Xie F, Thumboo J, Fong KY, Lo NN, Yeo SJ, Yang KY, Li SC, 'Are they relevant? A critical evaluation of the international classification of functioning, disability and health core sets for osteoarthritis from the perspective of patients with knee osteoarthritis in Singapore', VALUE IN HEALTH, 8 A27-A27 (2005)
DOI10.1016/S1098-3015(10)67219-1Author URL
2005Ong SC, Lim SG, Li SC, 'Validation of a Health-related Quality of Life Instrument for Hepatitis B patients in Singapore', Value in Health, 8 312-312 (2005) [C1]
2005Zhang XH, Wee HL, Tan K, Tan HH, Thumboo J, Li SC, 'Is Diabetes Knowledge Associated with Health-related Quality of Life among English-speaking Subjects with Diabetes in Singapore?', Value in Health, 8 365-366 (2005) [C1]
2005Koh Y, Fatimah MK, Li SC, 'Drug related problems in hospitalized patients on polypharmacy: The influence of age and gender', Therapeutics and Clinical Risk Management, 1 39-48 (2005) [C1]
2005Wee HL, Cheung YB, Fong KY, Li SC, Thumboo J, 'The Impact of Diabetes and other Chronic Medical Conditions on Health-related Quality of Life: Is the Whole Greater than the Sum of its Parts?', Health and Quality of Life Outcomes, 3 1-2 (2005) [C1]
DOI10.1186/1477-7525-3-2
2005Lau TC, Lau TC, Lim BP, Lim BP, Li SC, 'Cost-Effectiveness Analysis of Bisphosphonates and Raloxifene for Treatment of Osteoporosis and Prevention of Fractures.', Value in Health, 8 (3) (2005) [C3]
2005Xie F, Li SC, Thumboo J, 'Do the Important Health-Related Quality of Life Domains & Items in Knee & Hip Osteoarthritis Vary in Importance Across Social-Cultural Contexts? A Qualitative Systematic Literature Review', Seminars in Arthritis and Rheumatism, 34 793-804 (2005) [C1]
DOI10.1016/j.semarthrit.2005.02.003
CitationsWeb of Science - 13
2004Tsai WL, Chang HM, Hwu Y, Hsu PC, Tsai HI, Chow GM, et al., 'Imaging cells with refractive index radiology', Biophysical Journal, 87 4180-4187 (2004) [C1]
DOI10.1529/biophysj.103.034991
2004Li SC, Ong SC, Lim SG, Yeoh KG, Kwong SKS, Lee V, et al., 'A Cost Comparison of Management of Chronic Hepatitis B and its Associated Complications in Hong Kong and Singapore', Journal of Clinical Gastroenterology, 38 S136-S143 (2004) [C1]
DOI10.1097/00004836-200411003-00004
CitationsWeb of Science - 18
2004Hing WC, Bek SJ, Lin R, Li SC, 'Retrospective Drug Utilisation of Vancomycin in a paediatric hospital', Journal of Clinical Pharmacy and Therapeutics, 29 359-365 (2004) [C1]
DOI10.1111/j.1365-2710.2004.00571.x
CitationsWeb of Science - 7
2004Luo N, Koh Y, Tan CH, Kua EH, Li SC, 'Drug utilization review of risperidone for outpatients from a tertiary referral hospital in Singapore', Human Psychopharmacology, 19 259-264 (2004) [C1]
DOI10.1002/hup.585
CitationsWeb of Science - 2
2004Luo N, Fones CS, Thumboo J, Li SC, 'Factors influencing health-related quality of life in Asians with anxiety disorders in Singapore', Quality of Life Research, 13 557-565 (2004) [C3]
CitationsWeb of Science - 11
2004Wee HL, Goh SY, Li SC, Lim SG, Ong SC, Tan CE, Thumboo J, 'Is the influence of sociodemographic factors on EQ-5D scores affected by the underlying disease: A study in patients with chronic hepatitis B or diabetes mellitus.', Quality of Life Research, 13 (2004) [C3]
2004Doherty J, Kamae I, Lee K, Li H, Li SC, Liu G, et al., 'What''s Next for Pharmacoeconomics and Outcomes Research in Asia?', Value in Health, 7 118-132 (2004) [C1]
DOI10.1111/j.1524-4733.2004.72330.x
CitationsWeb of Science - 16
2004Zhou S, Chan E, Lim LY, Boelsterli UA, Li SC, Wang J, et al., 'Therapeutic drugs that behave as mechanism-based inhibitors of cytochrome P450 3A4', Current Drug Metabolism, 5 415-442 (2004) [C1]
DOI10.2174/1389200043335450
CitationsWeb of Science - 102
2004Gao F, Luo N, Thumboo J, Fones CS, Li SC, Cheung YB, 'Does the 12-item General Health Questionnaire contain multiple factors and do we need them?', Health and Quality of Life Outcomes, 2 63-63 (2004) [C1]
DOI10.1186/1477-7525-2-63
2004Koh Y, Fatimah HK, Fatimah MK, Li SC, 'Prevalence of drug-related problems amongst hospitalised patients on polypharmacy in Singapore.', Value in Health, 7 (3) (2004) [C1]
2003Koh DR, Ng SC, Yoon KH, Vasoo S, Li SC, Thumboo J, et al., 'Do English and Chinese EQ-5D versions demonstrate measurement equivalence? An exploratory study', Health and Quality of Life Outcomes, 1 1-7 (2003) [C1]
DOI10.1186/1477-7525-1-7
2003Chong LY, Chay OM, Li SC, 'Cultural adaptation and validation of Childhood Asthma Questionnaire-C (CAQ-C) in Singapore', Value in Health, 6(3) 374-375 (2003) [C3]
2003Wee HL, Li SC, 'Reliability and validity of KINDL children generic health-related quality of life questionnaire in an Asian school-based sample.', Value in Health, 6(3) (2003) [C3]
2003Luo N, Seng BK, Li SC, Thumboo J, 'Health-related quality of life in outpatients with schizophrenia in Singapore', Value in Health, 6 (6) 695-695 (2003) [C3]
2003Luo N, Tan LCS, Li SC, Thumboo J, 'Validation of Singaporean English and Chinese EQ-5D Versions in Patients with Parkinsons Disease', Value in Health, 6 (6) 769-769 (2003) [C3]
2003Li SC, 'An introduction to pharmacoeconomic evaluation in rheumatology', International Journal of Rheumatic Diseases, 6 192-200 (2003) [C1]
DOI10.1046/j.0219-0494.2003.00046.x
2003Luo N, Seng BK, Li SC, 'Identification of factors influencing caregiving experience in caregivers of patients with schizophrenia', Annals of the Academy of Medicine Singapore, 32 43-45 (2003) [C1]
2003Luo N, Fong KH, Koh DR, Ng SC, Yoon KH, Vascoo S, et al., 'Validity and Reliability of the EQ-5D Self-Report Questionnaire in Chinese-Speaking Patients with Rheumatic Diseases in Singapore', Annals of the Academy of Medicine Singapore, 32 685-690 (2003) [C1]
CitationsWeb of Science - 42
2003Luo N, Chew LH, Fong KY, Koh DR, Ng SC, Yoon KH, et al., 'A comparison of the EQ-5D and the health utilities index mark 3 (HUI3) in patients with rheumatic diseases', Journal of Rheumatology, 30 2268-2274 (2003) [C1]
CitationsWeb of Science - 32
2003Koh Y, Fatimah MK, Li SC, 'Therapy related hospital admission in patients on polypharmacy in Singapore: a pilot study', Pharmacy World and Science: international journal of clinical pharmacy and pharmaceutical care, 25 135-137 (2003) [C1]
DOI10.1023/A:1024896328720
CitationsWeb of Science - 11
2003Luo N, Li SC, Seng BK, Thumboo J, 'Construct Validity of the Health Utilities Index Mark 3 (HUI3) in Patients with Schizophrenia.', Qual Life Res, 7 (2003) [C1]
2003Luo N, Li SC, Seng BK, Thumboo J, 'Responsiveness of the Schizophrenia Quality of Life Scale (SQLS) and the Short Form 36 Health Survey (SF-36) in patients with Schizophrenia: A comparative Study.', Qual Life Res, 7 (2003) [C3]
2003Luo N, Fong KH, Koh DR, Ng SC, Yoon KH, Vascoo S, et al., 'Validity and Reliability of the ED-5D Self-Report Questionnaire in English-speaking Asian Patients with Rheumatic Diseases in Singapore', Quality of Life Research, 12 87-92 (2003) [C3]
CitationsWeb of Science - 51
2002Tan LC, Luo N, Nazri M, Li SC, Thumboo J, 'Validity and Reliability of the PDQ-39 and the PDQ-8 in English-speaking Parkinson''s Disease Patients in Singapore', Parkinsonism and Related Disorders, 10 493-499 (2002) [C1]
CitationsWeb of Science - 29
2002Qeuk JT, Li SC, 'A Study of the effectiveness of AIDS health education interventions among the adolescent population of Singapore.', Singapore Medical Journal, 43 279-283 (2002) [C1]
2002Wee WL, Ho HK, Li SC, 'Public awareness of diabetes mellitus in Singapore.', Singapore Medical Journal, 43 128-134 (2002) [C1]
2002Wee HL, Lee WW, Li SC, 'Psychometric evaluation of a generic HRQOL instrument (KID-KINDL) for self-assessment of HRQOL in Singaporean children with diabetes: A pilot study', Diab Res Clin Pract, 56(1) (2002) [C1]
2002Luo N, Chew LH, Koh DR, Ng SC, Yoon KH, Vascoo S, et al., 'Are Singaporean English and Chinese EQ-5D Versions psychometrically equivalent? An Exploratory Study', Quality of Life Research, 11 (2002) [C1]
2002Luo N, Chew LH, Koh DR, Ng SC, Yoon KH, Vascoo S, et al., 'Comparing the EQ-5D and Health Utilities Index (HUI-3) in Subjects with Rheumatic Diseases.', Quality of Life Research, 11 (2002) [C1]
2002Chong LY, Chay OM, Goh A, Seng YC, Li SC, 'Cultural adaptation and validation of Childhood Asthma Questionnaire Version B (CAQ-B) For Singapore Children.', Val Health, 5 (3) (2002) [C1]
2001Luo N, Leng S, Fongs C, Li SC, 'Validation of the medical outcomes study short-form 36 health survey (SF-36) for quality-of-life assessment of Chinese patients with anxiety disorders in Singapore', Quality of Life Res, 9 (2001) [C1]
2001Wee HL, Lee WR, Li SC, 'Evaluation of a generic quality-of-life instrument (KINDL) for self-assessment of QOL in Singaporean children with diabetes: a pilot study.', Val Health, 0 510-510 (2001) [C3]
2001Roy AN, Li SC, 'A Survey of Public Hospital Pharmacists in Singapore on their Views about The Formulary and its Decision-making Process.', Value in Health, 4 (2) (2001) [C1]
1996Wood PJ, IoannidesDemos LL, Li SC, Williams TJ, Hickey B, Spicer WJ, et al., 'Minimisation of aminoglycoside toxicity in patients with cystic fibrosis', THORAX, 51 369-373 (1996)
DOI10.1136/thx.51.4.369Author URL
CitationsWeb of Science - 36
1994MCLEAN AJ, BASTONE EB, IOANNIDESDEMOS LL, LI SC, CHRISTOPHIDIS N, SPICER WJ, 'INTERACTION OF GENTAMICIN PEAK AND TROUGH CONCENTRATIONS ON BACTERIAL KILL', CLINICAL PHARMACOLOGY & THERAPEUTICS, 55 192-192 (1994)
Author URL
1994IOANNIDESDEMOS LL, LI SC, BASTONE EB, SPELMAN DW, HOOPER RE, COUSINS VC, MCLEAN AJ, 'ABSENCE OF TOXICITY IN PATIENTS WITH MALIGNANT OTITIS-EXTERNA FOLLOWING LONG-TERM TREATMENT WITH HIGH DOSAGE TOBRAMYCIN', JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 34 267-274 (1994)
DOI10.1093/jac/34.2.267Author URL
CitationsWeb of Science - 9
1993IOANNIDESDEMOS LL, LI SC, BASTONE EB, SPICER WJ, 'BACTERICIDAL EFFECTS OF GENTAMICIN PEAK CONCENTRATIONS PROVIDE A RATIONALE FOR BOLUS ADMINISTRATION', CLINICAL PHARMACOLOGY & THERAPEUTICS, 53 194-194 (1993)
Author URL
1993IOANNIDESDEMOS LL, LI SC, SPELMAN DW, HOOPER RE, COUSINS V, BASTONE EB, MCLEAN AJ, 'RATIONALE AND INITIAL EXPERIENCE OF HIGH-DOSE AMINOGLYCOSIDE THERAPY OF MALIGNANT OTITIS-EXTERNA', CLINICAL PHARMACOLOGY & THERAPEUTICS, 53 194-194 (1993)
Author URL
1993BASTONE EB, LI SC, IOANNIDESDEMOS LI, SPICER WJ, MCLEAN AJ, 'KILL KINETICS AND REGROWTH PATTERNS OF ESCHERICHIA-COLI EXPOSED TO GENTAMICIN CONCENTRATION-TIME PROFILES SIMULATING INVIVO BOLUS AND INFUSION DOSING', ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 37 914-917 (1993)
Author URL
CitationsWeb of Science - 24
1993MCLEAN AJ, IOANNIDESDEMOS LL, LI SC, BASTONE EB, SPICER WJ, 'BACTERICIDAL EFFECT OF GENTAMICIN PEAK CONCENTRATION PROVIDES A RATIONALE FOR ADMINISTRATION OF BOLUS DOSES', JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 32 301-305 (1993)
DOI10.1093/jac/32.2.301Author URL
CitationsWeb of Science - 14
1992LI SC, IOANNIDESDEMOS LL, SPICER WJ, SPELMAN DW, TONG N, MCLEAN AJ, 'PROSPECTIVE AUDIT OF AN AMINOGLYCOSIDE CONSULTATIVE SERVICE IN A GENERAL-HOSPITAL', MEDICAL JOURNAL OF AUSTRALIA, 157 308-311 (1992)
Author URL
CitationsWeb of Science - 14
1992CORVAIA L, LI SC, IOANNIDESDEMOS LL, BOWES G, SPICER WJ, SPELMAN DW, et al., 'A PROSPECTIVE-STUDY OF THE EFFECTS OF ORAL PROBENECID ON THE PHARMACOKINETICS OF INTRAVENOUS TICARILLIN IN PATIENTS WITH CYSTIC-FIBROSIS', JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 30 875-878 (1992)
DOI10.1093/jac/30.6.875Author URL
CitationsWeb of Science - 4
1991LI SC, BOWES G, IOANNIDESDEMOS LL, SPICER WJ, HOOPER RE, SPELMAN DW, et al., 'DOSAGE ADJUSTMENT AND CLINICAL OUTCOMES OF LONG-TERM USE OF HIGH-DOSE TOBRAMYCIN IN ADULT CYSTIC-FIBROSIS PATIENTS', JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 28 561-568 (1991)
DOI10.1093/jac/28.4.561Author URL
CitationsWeb of Science - 6
1989LI SC, IOANNIDESDEMOS LL, SPICER WJ, BERBATIS C, SPELMAN DW, TONG N, MCLEAN AJ, 'PROSPECTIVE AUDIT OF AMINOGLYCOSIDE USAGE IN A GENERAL-HOSPITAL WITH ASSESSMENTS OF CLINICAL PROCESSES AND ADVERSE CLINICAL OUTCOMES', MEDICAL JOURNAL OF AUSTRALIA, 151 224-& (1989)
Author URL
CitationsWeb of Science - 23
Show 143 more journal articles

Review (3 outputs)

YearCitationAltmetricsLink
2005Zhang J, Tian Q, Chan SY, Duan W, Li SC, Zhu YZ, Zhou SF, 'Metabolism and Transport of Oxazaphosphorines and the Clinical Implications.', Drug Metabolism Review (2005) [D1]
CitationsWeb of Science - 86
2004Zhou S, Chan E, Li SC, Huang M, Li X, Zhang Q, 'Predicting pharmacokinetic herb-drug in', Drug Metabolism and Drug Interaction (2004) [D1]
2003Li SC, 'An Overview of Community pharmacist interventions: Assessing cost-effectiveness and patients willingness to pay', Disease Management and Health Outcomes (2003) [D1]
CitationsWeb of Science - 3

Conference (94 outputs)

YearCitationAltmetricsLink
2014Gao L, Li SC, 'COST-EFFECTIVENESS OF TREATING ACUTE CORONARY SYNDROME PATIENTS WITH RIVAROXBAN IN AUSTRALIA', VALUE IN HEALTH (2014) [E3]
Author URL
2014Tahir MNA, Li SC, Thomas P, 'CHALENGES AND OPORTUNITIES IN THE MALAYSIAN HEALTH CARE SYSTEM', VALUE IN HEALTH (2014) [E3]
Author URL
2013Gao L, Walterfang M, Velakoulis D, Li SC, 'VALIDATION OF A CHINESE VERSION OF NEUROPSYCHIATRY UNIT COGNITIVE ASSESSMENT TOOL (NUCOG)', VALUE IN HEALTH (2013) [E3]
Author URL
2012Zhang F, Li SC, Du J, 'SATISFACTION ASSESSMENT OF INSURANCE SYSTEM FOR URBAN RESIDENTS (URMS) OF UNIVERSITY STUDENTS IN SHENYANG', VALUE IN HEALTH (2012) [E3]
Author URL
2012Zhang F, Du J, Li SC, 'Satisfaction assessment of insurance system for urban residents (URMS) of university students in Shenyang', Value in Health, Washington, DC (2012) [E3]
2012Gao L, Li SC, 'Cost-utility analysis of liraglutide versus glimepiride as add-on to metformin in patients with type 2 diabetes in China', Value in Health, Berlin, Germany (2012) [E3]
2012Gao L, Li SC, 'Statin is a reasonable treatment option for patients with polysystic ovary syndrome: A meta-analysis of randomized controlled trials', Value in Health, Berlin, Germany (2012) [E3]
2012Zhao F, Xie F, Li SC, 'Transferability of indirect cost of chronic disease: A systematic review and meta-analysis', Value in Health: ISPOR 15th Annual European Congress and ISPOR 5th Asia-Pacific Conference, Berlin, Germany (2012) [E3]
2012Tu HAT, Coyte P, Li SC, Postma MJ, 'Cost-effectiveness of rotavirus immunization in Vietnam: Exploring impacts of herd immunity and patterns of breastfeeding of', Value in Health: ISPOR 15th Annual European Congress and ISPOR 5th Asia-Pacific Conference, Berlin, Germany (2012) [E3]
2012Thoopputra T, Li SC, Newby DA, Schneider JJ, 'Pharmaceutical care intervention for disease management in community pharmacies in Australia', Value in Health: ISPOR 15th Annual European Congress and ISPOR 5th Asia-Pacific Conference, Berlin, Germany (2012) [E3]
Co-authorsDavid Newby, Jennifer Schneider
2012Thoopputra T, Newby DA, Schneider JJ, Li SC, 'Awareness and perception of diabetes risk assessment in community pharmacy in Australia', Research in Social and Administrative Pharmacy: Workshop and Presentation Abstracts from the 17th International Social Pharmacy Workshop, Phuket, Thailand (2012) [E3]
Co-authorsDavid Newby, Jennifer Schneider
2011Zhang F, Li SC, Fu S, Xie J, Zhang Y, Kong L, 'What is important during the pharmacoeconomic evaluation of CAM (complementary and alternative medicine)?- A survey research', Value in Health, Baltimore, MD (2011) [E3]
2011Tu HAT, Rozenbaum M, Coyte PC, Li SC, Postma MJ, 'Cost-effectiveness of rotavirus immunization in Vietnam: Results and challenges', Value in Health, Baltimore, MD (2011) [E3]
2011Thoopputra T, Li SC, Newby DA, Schneider JJ, 'A literature review of diabetes risk assessment tools', Value in Health, Baltimore, MD (2011) [E3]
Co-authorsJennifer Schneider, David Newby
2010Xie F, Pullenayegum E, Li SC, 'USE OF A DISEASE-SPECIFIC INSTRUMENT IN ECONOMIC EVALUATIONS: MAPPING WOMAC ONTO THE EQ-5D UTILITY INDEX', VALUE IN HEALTH (2010) [E3]
DOI10.1016/S1098-3015(10)72660-7Author URL
2010Zhao FL, Yue M, Wu JH, Yang H, Wang T, Li SC, 'VALIDATION AND COMPARISON OF EUROQOL AND SHORT FORM 6D IN CHINESE CHRONIC PROSTATITIS PATIENTS', VALUE IN HEALTH (2010) [E3]
DOI10.1016/S1098-3015(10)72898-9Author URL
CitationsWeb of Science - 1
2010Xie F, Pullenayegum E, Li SC, 'Use of disease-specific instrument in economic evaluations: Mapping Womac into the EQ-5D utility index', Value in Health, Atlanta, GA (2010) [E3]
DOI10.1111/j.1524-4733.2010.00770.x
CitationsScopus - 18Web of Science - 16
2010Zhao F, Yue M, Wu JH, Yang H, Wang T, Li SC, 'Validation and comparison of euroqol and short form 6D in chronic prostatitis patients', Value in Health, Atlanta, GA (2010) [E3]
DOI10.1111/j.1524-4733.2010.00728.x
CitationsScopus - 16Web of Science - 14
2010Pongmesa T, Li SC, Wee HL, 'Development of a Thai version of The Audit of Diabetes-Dependent Quality of Life (ADDQOL-19) Questionnaire: Linguistic and psychometric evaluation', Value in Health, Phuket, Thailand (2010) [E3]
2010Pongmesa T, Wee HL, Li SC, 'Health status, health-related quality of life and treatment satisfaction among patients with diabetes in Thailand', Value in Health, Phuket, Thailand (2010) [E3]
2010Tu HAT, Riewpaiboon A, Woerdenbag HJ, Postma MJ, Li SC, 'Cost-of-illness of chronic hepatitis B infection in Vietnam', Value in Health, Phuket, Thailand (2010) [E3]
2010Zhao F, Yue M, Yang H, Wang T, Wu JH, Li SC, 'Willingness to pay per quality adjusted life-year: Is one threshold applicable for all decision-making', Value in Health, Phuket, Thailand (2010) [E3]
CitationsWeb of Science - 1
2010Zhao F, Yue M, Yang H, Wang T, Wu JH, Li SC, 'Health-related quality of life in Chinese chronic prostatitis patients', Value in Health, Phuket, Thailand (2010) [E3]
DOI10.1007/s11136-010-9697-2
CitationsScopus - 10
2009Zhao FL, Li SC, 'A SYSTEMATIC REVIEW OF BURDEN OF DISEASE STUDIES IN THE ASIA-PACIFIC REGION', VALUE IN HEALTH (2009) [E3]
DOI10.1016/S1098-3015(10)73176-4Author URL
2009Xie F, Ye H, Zhang Y, Liu X, Lei T, Li SC, 'EXTENSION FROM INPATIENTS TO OUTPATIENTS: PERFORMANCE OF THE OXFORD KNEE SCORE IN MEASURING HEALTH OUTCOMES IN PATIENTS WITH KNEE OSTEOARTHRITIS', VALUE IN HEALTH (2009) [E3]
DOI10.1016/S1098-3015(10)73420-3Author URL
2009Zhao YJ, Tan LC, Seah SH, Lau PN, Au WL, Li SC, et al., 'RATE OF DISEASE PROGRESSION AMONG PATIENTS WITH PARKINSON'S DISEASE IN SINGAPORE', VALUE IN HEALTH (2009) [E3]
DOI10.1016/S1098-3015(10)74011-0Author URL
2009Xie F, Ye H, Zhang Y, Liu X, Lei T, Li SC, 'Extension from inpatients to outpatients: Performance of the Oxford Knee Score in measuring health outcomes in patients with knee osteoarthritis', Value in Health, Orlando, FL (2009) [E3]
DOI10.1111/j.1524-4733.2009.00537_2.x
2009Zhao YJ, Tan LC, Seah SH, Lau PN, Au WL, Li SC, et al., 'Rate of disease progression among patients with Parkinson's disease in Singapore', Value in Health, Orlando, FL (2009) [E3]
DOI10.1111/j.1524-4733.2009.00537_2.x
2009Zhao F, Li SC, 'A systematic review of burden of disease studies in the Asia-Pacific region', Value in Health, Orlando, FL (2009) [E3]
DOI10.1111/j.1524-4733.2009.00537_2.x
2009Zhao F, Wu JH, Yue M, Li SC, 'Willingness to pay per quality-adjusted life year of chronic prostatits patients in China', Value in Health, Paris, France (2009) [E3]
2008Pongmesa T, Li SC, Wee HL, 'A comparison of diabetes knowledge among residents in Bangkok and other central provinces of Thailand', Value in Health, Athens, Greece (2008) [E3]
2008Pongmesa T, Wee HL, Li SC, 'A survey of diabetes knowledge among the general population in Thailand', ISPOR 3rd Asia-Pacific Conference. Abstracts, Seoul, South Korea (2008) [E3]
2008Li SC, Nguyen T, 'Cost analysis between valproate and lithium in the management of biopolar disorder: Results from a multinational study (Vlaid study - valproate versus lithium in bipolar disorders', ISPOR 3rd Asia-Pacific Conference. Abstracts, Seoul, South Korea (2008) [E3]
2008Zhao YJ, Tan LC, Lau PN, Au WL, Li SC, Luo N, 'Determination of the longitudinal validity and minimally important difference of the 8-item Parkinson's disease questionnaire (PDQ-8)', Value in Health, Toronto, ONT (2008) [E3]
2007Zhang XH, Li SC, Xie F, Lo NN, Yang KY, Yeo SJ, Thomboo J, 'Investigation of response shift in health-related quality of life among patients undergoing total knee replacement', Value in Health, Dublin, Ireland (2007) [E3]
DOI10.1111/j.1524-4733.2007.00263_2.x
2007Jin J, Sklar GE, Oh MS, Li SC, 'What factors affect compliance of hypertensive patients with their treatment?: A qualitative study', Value in Health, Dublin, Ireland (2007) [E3]
2007Zhao YJ, Tan LC, Lau PN, Au WL, Li SC, Luo N, 'Identifications of Factors Affecting Quality of Life in Patients with Parkinsons Disease', Budapest, Hungary (2007) [E4]
2007Ong SC, Lim SG, Li SC, 'Cultural Adaptation and Validation of A Health-Related Quality of Life Questionnaire for English-speaking Hepatitis B patients in Singapore', Arlington, West Virginia, USA (2007) [E4]
2007Ngorsuraches S, Lerkiatbundit S, Li SC, Sirithorn R, Korwiwattanakarn M, 'Development and Validation of Patients Trust Scale in Community Pharmacist (TRUST-Ph)', Atlanta, USA, (2007) [E4]
2006Zhang XH, Xie F, Wee HL, Thumboo J, Li SC, 'Applying the Expectancy-Value Model to understand Health Preference - An Exploratory Study.', -, Philadelphia, PA, USA, (2006) [E1]
2006Fong K, Lo N, Yeo S, Yang K, Li SC, Xie F, Thumboo J, 'Are they measurable? A Study on Eliciting Indirect and Intangible Costs of Knee Osteoarthritis Using Human Capital Approach and Willingness-to-Pay in Multiethnic Asian Population in Singapore.', Value in Health, Copenhagen (2006) [E3]
DOI10.1016/S1098-3015(10)63270-6
2006Zhang XH, Ngorsuraches S, Li SC, 'Development and Validation of a scale to measure patients trust in pharmacists', Proceedings of the ISPOR 11th Annual International Meeting, Philadelphia, PA, USA, (2006) [E1]
2006Li SC, Zhang X, Xie F, Luo N, Cheung Y, Machin D, et al., ''The Impact of Discussing Death on Health Preferences: A Pilot Study in A Multi-Ethnic Asian Population', 17th Annual EuroQol Group Plenary Meeting, Barcelona (2006) [E3]
2006Ngorsuraches S, Li SC, 'Barriers to pharmaceutical care in Thailand', ISPOR 2nd Asia-Pacific Conference, Shanghai (2006) [E3]
2006Koh Y, Yap C, Li SC, 'Developing a qualitative scoring system for adverse drug reaction assessment using genetic algorithm', ISPOR 2nd Asia-Pacific Conference, Shanghai (2006) [E3]
2006Yap K, Su J, Li SC, Ho P, ''Nanoparticulate Delivery System of Carboplatin', Proceedings of 18th Singapore Pharmacy Congress, Singapore (2006) [E3]
2006Jin J, Li SC, 'A Review of Factors affecting Therapeutic Compliance', Proceedings of 18th Singapore Pharmacy Congress, Singapore (2006) [E3]
2006Zhang XH, Ngorsuraches S, Li SC, 'Development and Validation of a scale to measure patients trust in pharmacists', Proceedings of 18th Singapore Pharmacy Congress, Singapore (2006) [E1]
CitationsScopus - 3Web of Science - 5
2006Koh Y, Lee YM, Fatimah MK, Li SC, 'The Economic Value of Pharmacists - Participation in Physicians-Pharmacists Review Team.', Proceedings of 18th Singapore Pharmacy Congress, Singapore (2006) [E3]
2006Li SC, Iloeje U, Yuan Y, Lim S, ''A modelled economic implication of replacing lamivudine with entecavir in chronic hepatitis B (ChB) patients in Singapore.', Proceedings of 21st Annual Scientific Meeting of Singapore Society of Gastroenterologists, Singapore (2006) [E3]
2006Wee HL, Li SC, Xie F, Zhang XH, Luo N, Cheung YB, et al., 'How do survey respondents interpret and utilize symbols used in health valuation studies', Proceedings of ISPOR 2nd Asia Pacific Conference, Shanghai (2006) [E3]
2006Wee HL, Li SC, Xie F, Zhang XH, Luo N, Cheung YB, et al., 'Feasibility and acceptability of TTO and SG and factors influencing their acceptance for health valuation among Singaporeans', Proceedings of ISPOR 2nd Asia Pacific Conference, Shanghai (2006) [E3]
2006Wee HL, Li SC, Xie F, Zhang XH, Luo N, Cheung YB, et al., 'The impact of talking about death on health state valuation: A study among Chinese and Indian Singaporeans', Proceedings of ISPOR 2nd Asia Pacific Conference, Shanghai (2006) [E3]
2006Koh Y, Lee Y, Fatimah M, Ang Y, Li SC, ''The Clinical & Economic Value of Pharmacists Participation in Physicians-Pharmacists Review Team', Proceedings of National Healthcare Group Annual Scientific Congress, Singapore (2006) [E3]
2005Lau TC, Lim BP, Li SC, 'Cost-Effectiveness Analysis of Bisphosphonates and Raloxifene for Treatment of Osteoporosis and Prevention of Fractures.', -, Washington, DC, USA (2005) [E1]
2005Xie F, Thumboo J, Li SC, 'Are they Relevant? A Critical Evaluation of the International Classification of Functioning, Disability and Health Core Sets for Osteoarthritis from the Perspective of Patients with Knee Osteoarthritis in Singapore', -, Palazzo Degli Affari, Florence, Italy (2005) [E1]
2005Guo X, Tan S, Luo N, Li SC, 'The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): Validation of English and Chinese Versions in Singapore', Proceedings of 15th Science Research Congress, Singapore (2005) [E3]
2005Lim X, Wong L, Li SC, 'Usage of Alternative and Complementary Medicines in Singapore', Proceedings of 17th Singapore Pharmacy Congress, Singapore (2005) [E3]
2005Wee Y, Chui W, Li SC, 'A Study of Pharmacists - Understanding, Attitude. And Practice of Pharmaceutical Care in Singapore', Proceedings of 17th Singapore Pharmacy Congress & Inaugural NUS Pharmacy Intervarsity Congress, Singapore (2005) [E3]
2005Zhang XH, Wee HL, Tan K, Tan HH, Thumboo J, Li SC, 'An Exploratory Study of the Equivalence between the English and Chinese Versions of the Audit of Diabetes-Dependent Quality of Life (ADDQOL) based on the Universalist Approach.', Quality of Life Research, San Francisco, USA (2005) [E1]
2005Zhang XH, Zhang XH, Wee HL, Wee HL, Tan K, Tan K, et al., 'Is Diabetes Knowledge Associated with Health-related Quality of Life among English-speaking Subjects with Diabetes in Singapore?', Washington, DC, USA (2005) [E3]
2005Ong SC, Lim SG, Yeoh KY, Li SC, 'A Cost Analysis of Chronic Hepatitis B Infection & Its Associated Complications in Singapore', Singapore (2005) [E4]
2005Wee HL, Zhang XH, Tan K, Tan HH, Thumboo J, Li SC, 'Reliability and Validity of the General Diabetes Knowledge Test', Washington, DC, USA (2005) [E4]
2004Li SC, 'Pharmacoeconomics: Uses in Practice and Research in Singapore', Beijing, China (2004) [E4]
2004Wee HL, Goh SY, Li SC, Tan CE, Thumboo J, 'Does the generic EQ-5D function as well as disease-specific ADDQOL in persons with diabetes?', Hong Kong (2004) [E4]
2004Tan CE, Thumboo J, Wee HL, Goh SY, Li SC, Lim SG, Ong SC, 'Is the influence of sociodemographic factors on EQ-5D scores affected by the underlying disease: A study in patients with cronic hepatitis B or diabetes mellitus.', Quality of Life Research 2005, Hong-Kong (2004) [E1]
2004Koh Y, Fatimah HK, Fatimah MK, Li SC, 'Prevalence of drug-related problems amongst hospitalised patients on polypharmacy in Singapore.', Arlington, West Virginia, USA (2004) [E1]
2004Xie F, Luo N, Li SC, 'The European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ-C30): Validation of English version in Singapore', Arlington, West Virginia, USA (2004) [E1]
2003Keung X, Chiu W, Li SC, ''A survey of consumers on the provision of professional advice given by community pharmacists on self-medication', 16th Singapore Pharmacy Congress, Singapore (2003) [E3]
2003Ang Y, Chiu W, Li SC, 'Survey of Community Pharmacists on the Provision of Professional Advice to consumers who seeks self-medication for minor aliment management', Proceedings of 16th Singapore Pharmacy Congress, Singapore (2003) [E3]
2003Koh Y, Chan C, Li SC, ''Comparison of five established adverse drug reaction algorithms in a patient sample in Singapore', Proceedings of European Society of Clinical Pharmacy 4th Spring Conference, Lisbon (2003) [E3]
2003Seng B, Luo N, Li SC, ''The psychological distress in caregivers of patients with schizophrenia in Singapore', Proceedings of the NHG Annual Scientific Congress 2003, Singapore (2003) [E3]
2003Luo N, Li SC, Seng BK, Thumboo J, 'Construct Validity of the Health Utilities Index Mark 3 (HUI3) in Patients with Schizophrenia.', Quality of Life Research 2003, Prague Czech Republic (2003) [E1]
2003Luo N, Li SC, Seng BK, Thumboo J, 'Responsiveness of the Schizophrenia Quality of Life Scale (SQLS) and the Short Form 36 Health Survey (SF-36) in patients with Schizophrenia: a comparative study.', Quality of Life Research 2003, Prague Czech Republic (2003) [E1]
2003Luo N, Seng BK, Thumboo J, Li SC, 'Health-related quality of life in outptients with schizophrenia in Singapore.', Value in Health, Barcelona Spain (2003) [E1]
2003Wee HL, Li SC, 'Reliability and validity of KINDL children generic health related quality of life questionnaire in an Asian school based sample', Value in Health, Virginia USA (2003) [E1]
2003Chong LY, Chay OM, Li SC, 'Cultural adaptation and validation of Childhood Asthma Questionnaire-C', Value in health 2003, Virginia USA (2003) [E1]
2003Luo N, Tan LC, Li SC, Thumboo J, 'Validation of Singaporean English and Chinese EQ-5D Versions in Patients with Parkinsons Disease', Value in health 6, Barcelona Spain (2003) [E1]
2003Luo N, Seng BK, Thumboo J, Li SC, 'Validation of English and Chinese versions of the SQLS, the SF-36 and the HUI3 in Patients with Schizophrenia in Singapore.', Value in Health, USA (2003) [E3]
CitationsWeb of Science - 1
2002Li SC, 'A Survey on Consumers - Behaviours in the Purchase of Medicines', First Health Sciences Authority Scientific Seminar, Singapore (2002) [E3]
2002Fatimah M, Li SC, ''Pilot Study to quantify the Extent of Polypharmacy in Alexandra Hospital in the Geriatric Population', Proceedings of 15th Singapore Pharmacy Congress, Singapore (2002) [E3]
2002Koh Y, Fatimah M, Li SC, 'Prevalence of Drug Therapy Related Hospital Admission and its Association with Polypharmacy and Age of Patients in Singapore', Proceedings of 15th Singapore Pharmacy Congress, Singapore (2002) [E3]
2002Li SC, Yeoh T, Yeo S, Lin R, ''An Audit of Antimicrobial Surgical Prophylaxis in Pediatric Patients in Singapore', Proceedings of FIP 62nd International Congress, Nice (2002) [E3]
2002Seng B, Luo N, Li SC, ''Validation of the Experience of Caregiving Inventory (ECI) and the Burden Assessment Scale (BAS) in English-speaking Caregivers of Patients with Schizophrenia in Singapore', Proceedings of the 1st Scientific Meeting of the National Healthcare Group, Singapore (2002) [E3]
2002Luo N, Seng B, Thumboo J, Li SC, 'Validation of the Schizophrenia Quality of Life Scale (SQLS) and the Short Form 36 Health Survey (SF-36) in English-speaking Patients with Schizophrenia in Singapore', Proceedings of the 1st Scientific Meeting of the National Healthcare Group, Singapore (2002) [E3]
2002Luo N, Chew LH, Koh DR, Ng SC, Yoon KH, Vascoo S, et al., 'Are Singaporean English and Chinese EQ-5D Versions psychometrically equivalent? An Exploratory Study', Orlando, USA (2002) [E1]
2002Chong LY, Chay OM, Goh A, Seng YC, Li SC, 'Cultural adaptation and validation of Childhood Asthma Questionnaire Version B (CAQ-B) For Singapore Children.', Arlington, Virginia, USA (2002) [E1]
2002Wee HL, Lee WW, Li SC, 'Psychometric evaluation of a generic HRQOL instrument (KID-KINDL) for self-assessment of HRQOL in Singaporean children with diabetes: A pilot study', Beijing, China (2002) [E1]
2002Vascoo S, Li SC, Thumboo J, Luo N, Chew LH, Koh DR, et al., 'Comparing the EQ-5D and Health Utilities Index (HUI-3) in Subjects with Rheumatic Diseases.', Orlando, USA (2002) [E1]
2001Luo N, Fones C, Li SC, 'A study of the Quality of Life in patients with anxiety disorders in Singapore', Proceedings of FIP 61st International Congress, Singapore (2001) [E3]
2001Ku H, Tan M, Li SC, 'Attitude and knowledge towards Traditional Medicine among Singaporeans', Singapore Traditional Chinese Medicine (TCM) Research Symposium 2001, Singapore (2001) [E3]
2001Luo N, Chew LH, Fong KY, Ng SC, Yoon KH, Li SC, Thumboo J, 'Validity and Reliability of EQ-50 Domains in Asians in Singapore with Rheumatic Diseases', Amsterdam, The Netherlands (2001) [E1]
2001Roy AN, Li SC, 'A Survey of Public Hospital Pharmacists in Singapore on their Views about The Formulary and its Decision-making Process.', Arlington, VA, USA (2001) [E1]
2001Luo N, Leng S, Fongs C, Li SC, 'Validation of the medical outcomes study short-form 36 health survey (SF-36) for quality-of-life assessment of Chinese patients with anxiety disorders in Singapore' (2001) [E1]
Show 91 more conferences
Edit

Grants and Funding

Summary

Number of grants1
Total funding$15,000

Click on a grant title below to expand the full details for that specific grant.


20121 grants / $15,000

TBA$15,000

Funding body: Newcastle & Hunter Valley Pharmacists Association Inc

Funding bodyNewcastle & Hunter Valley Pharmacists Association Inc
Project TeamProfessor Shu Chuen Li, Mr Hao Hu
SchemeResearch Grant
RoleLead
Funding Start2012
Funding Finish2012
GNoG1200632
Type Of FundingGrant - Aust Non Government
Category3AFG
UONY
Edit

Research Supervision

Current Supervision

CommencedResearch Title / Program / Supervisor Type
2014Identification and Classification of Adverse Drug Reactions in China: Development and Validation of a Quantitative Combined System Using Generic Algorith
Pharmacy, Faculty of Health and Medicine
Principal Supervisor
2014Improvement of Quality Use of Medicine in Chronic Respiratory Diseases
Pharmacy, Faculty of Health and Medicine
Principal Supervisor
2014Development of an Appropriate Screening Tool for Depression for Australian Pharmacists
Pharmacology, Faculty of Health and Medicine
Co-Supervisor
2013Quality use of Medicines in Malaysian Public Health System: The Role of Pharmacists
Pharmacy, Faculty of Health and Medicine
Principal Supervisor
2012Health Related Quality of Life and Economic Burden of Prevalent Chronic Diseases in China
Pharmacy, Faculty of Health and Medicine
Principal Supervisor
2012Potential Cardio-Protective Effect of Pneumococcal Vaccine
Pharmacology, Faculty of Health and Medicine
Co-Supervisor
2008The Cost Effective Management of Osteoporosis to Prevent Fractures in Singapore
Pharmacy, Faculty of Health and Medicine
Principal Supervisor
2008Pharmacovigilance and development of signal detection algorithm for drug safety monitoring
Pharmacy, Faculty of Health and Medicine
Principal Supervisor
2006Pharmacoeconomic study of Parkinson's Disease in Singapore
Pharmacy, Unknown
Principal Supervisor
2006A comparison of the impact of pharmaceutical care in diabetic patients in Singapore and Thailand
Pharmacy, Unknown
Principal Supervisor
2006Impact of therapeutic compliance on clinical and economic outcomes
Pharmacy, Unknown
Principal Supervisor
2005Methodlogical Issues in Pharmacoeconomics and Outcomes Research
Pharmacy, Unknown
Principal Supervisor

Past Supervision

YearResearch Title / Program / Supervisor Type
2015How to Implement Quality Use of Medicines in Developing Countries - An Example from China
Pharmacy, Faculty of Health and Medicine
Principal Supervisor
2014Risk Management for Type 2 Diabetes in Community Pharmacy Practice
Pharmacy, Faculty of Health and Medicine
Principal Supervisor
2011Evidence-Based Reimbursement Decision-Making in Asia-Pacific Region: Transferability of the Economic Evaluation Between Different Jurisdictions
Pharmacy, Faculty of Health and Medicine
Principal Supervisor
Edit

Professor Shu Chuen Li

Position

Professor
School of Biomedical Sciences and Pharmacy
Faculty of Health and Medicine

Focus area

Pharmacy and Experimental Pharmacology

Contact Details

Emailshuchuen.li@newcastle.edu.au
Phone(02) 4921 5921
Fax(02) 492 17903

Office

RoomMS108
BuildingMedical Sciences
LocationCallaghan
University Drive
Callaghan, NSW 2308
Australia
Edit